Hormone selectivity in thyroid hormone receptors

Molecular Endocrinology

Volumn 15, Issue 3, 2001, Pages 398-410

  Wagner, Richard L ^a   Huber, B Russell ^b   Shiau, Andrew K ^a   Kelly, Alex ^b   Cunha Lima, Suzana T ^a   Scanlan, Thomas S ^b   Apriletti, James W ^a   Baxter, John D ^a   West, Brian L ^a   Fletterick, Robert J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIMETHYL 4 (4' HYDROXY 3' ISOPROPYLBENZYL)PHENOXYACETIC ACID; ACETIC ACID DERIVATIVE; AMINO ACID; ASPARAGINE; SERINE; THYROID HORMONE RECEPTOR; TIRATRICOL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; GENETIC CODE; HORMONE ACTION; HORMONE STRUCTURE; HUMAN; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN STRUCTURE; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

EID: 17744379363     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.3.0608     Document Type: Article

References (49)

1. The nuclear receptor superfamily: The second decade
2. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
3. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
4. The thyroid: Physiology, thyrotoxicosis, hypothyroidism, and the painful thyroid
5. Cardiac arrhythmias and heart rate in hyperthyroidism
6. The c-erb-A protein is a high-affinity receptor for thyroid hormone
7. The c-erb-A gene encodes a thyroid hormone receptor
8. Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system
9. Thyroid hormone receptors: Multiple forms, multiple possibilities
10. A unique role of the β-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation
11. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone
12. Nuclear-receptor ligands and ligand-binding domains
13. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor α
14. Evidence that decreased heart rate in thyroid hormone receptorα1-deficient mice is an intrinsic defect
15. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α1
16. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation
17. Different functions for the thyroid hormone receptors TRα and TRβ in the control of thyroid hormone production and post-natal development
18. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor
19. The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity
20. A structural role for hormone in the thyroid hormone receptor
21. A novel TRβ mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation
22. Structural determinants of nuclear receptor assembly on DNA direct repeats
23. The steroid and thyroid hormone receptor superfamily
24. An essential role of domain D in the hormone-binding activity of human β 1 thyroid hormone nuclear receptor
25. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
26. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
27. A canonical structure for the ligand-binding domain of nuclear receptors
28. Nonbiased identification of DNA sequences that bind thyroid hormone receptor α 1 with high affinity
29. A role for helix 3 of the TRβ ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone
30. Molecular basis of agonism and antagonism in the oestrogen receptor
31. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
32. Structure and specificity of nuclear receptor-coactivator interactions
33. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
34. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
35. Natural ligands of nuclear receptors have conserved volumes
36. Crystal structure of the human RXRα ligand-binding domain bound to its natural ligand: 9-cis retinoic acid
37. Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRAR-γ
38. Thyroid hormones and analogs. II. Structure-activity relationships
39. Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronine
40. Nomenclature of thyroid hormone receptor-β gene mutations in resistance to thyroid hormone: Consensus statement from the First Workshop on Thyroid Hormone Resistance, 10-11th July 1993, Cambridge, UK
41. Expression of the rat α 1 thyroid hormone receptor ligand binding domain in Escherichia coli and the use of a ligand-induced conformation change as a method for its purification to homogeneity
42. Preliminary crystallographic studies of the ligand-binding domain of the thyroid hormone receptor complexed with triiodothyronine
43. Processing of x-ray diffraction data collected in oscillation mode
44. The CCP4 suite: Programs for protein crystallography
45. OOPS-a-daisy
46. Crystallography and NMR system: A new software suite for macromolecular structure determination
47. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structure
48. Raster3D: Photorealistic molecular graphics
49. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice